Navigation Links
Digirad Names Richard B. Slansky Chief Financial Officer
Date:2/17/2009

POWAY, Calif., Feb. 17 /PRNewswire-FirstCall/ -- Digirad Corporation (Nasdaq: DRAD), a leading provider of diagnostic imaging products, and personnel and equipment leasing services, today announced that it has named veteran financial executive Richard B. Slansky as Chief Financial Officer of the Company, effective March 9, 2009, replacing Interim Chief Financial Officer Todd Clyde, who will continue to serve as President and Chief Executive Officer.

With more than 25 years of experience as a Chief Financial Officer at both public and private companies, Slansky, 51, has served for the past six years as the President and Chief Financial Officer of Poway, Calif.-based SpaceDev, Inc., a publicly traded space technology/aerospace company acquired by privately held Sierra Nevada Corporation in December.

Clyde said, "Richard has the breadth of background and expertise that will make him a key part of the Digirad executive team. His financial background and strong performance record of improving efficiency and supporting organizational growth will be critical as we progress toward consistent profitability and positive cash flow while further penetrating our markets. We look forward to welcoming Richard to the senior management team and to the positive contributions he will bring to the role."

Prior to SpaceDev, Slansky served as Interim Chief Financial Officer for Woodlands, Tex.-based Quick Strike Resources. He has also served as Chief Financial Officer at Path 1 Network Technologies, Inc; Nautronix, Inc.; Alexis Corporation; and Calbiochem-Novabiochem International (aka C-N Biosciences), all located in the greater San Diego, Calif. area.

He received a Master's in Business Administration from the University of Arizona and a bachelor's degree in Economics from the University of Pennsylvania. Slansky also completed select continuing education courses for the California Council for Quality and Service Board of Examiners, American Society of Quality Control's ISO 9000 Implementation, San Diego State University's Executive Challenge Program and the American Management Association's Course for Presidents. He currently resides in Poway, Calif.

About Digirad Corporation

Digirad provides medical diagnostic imaging systems and personnel and equipment leasing services to physicians' offices, hospitals and imaging centers for cardiac, vascular, and general imaging applications. Digirad's Cardius XPO line of nuclear imaging cameras use patented solid-state technology and unique multi (single, dual, triple) head design for superior performance and advanced features for sharper digital images, faster processing, compact size, lighter weight for portability, ability to handle patients up to 500 pounds, and improved patient comfort compared to standard nuclear cameras. Digirad's 2020tc general-purpose nuclear imager has a small footprint and may also be configured for fixed or mobile use to supplement primary imaging. Digirad's installed base of equipment exceeds 600 systems; in addition, a mobile fleet of more than 145 nuclear and ultrasound imaging systems is being used in 21 states, primarily in the eastern, midwestern and southwestern United States. For more information, please visit www.digirad.com. Digirad(R), Digirad Imaging Solutions(R), and Cardius(R) are registered trademarks of Digirad Corporation.

Forward-Looking Statements

This press release contains statements that are forward-looking statements as defined within the Private Securities Litigation Reform Act of 1995. These include statements regarding the efficacy of Digirad's centers of influence model, the status of the negotiation of the sale or closure of underperforming hub locations, and the ability to achieve positive cash flow and profitability, drive technology progress and improve services utilization to grow market share. These forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from the statements made, including the risks associated with changes in business conditions, technology, customers' business conditions, work force, suppliers, business prospects, economic outlook, operational policy or structure, acceptance and use of Digirad's camera systems and services, reliability, recalls, and other risks detailed in Digirad's filings with the U.S. Securities and Exchange Commission, including Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and other reports. Readers are cautioned to not place undue reliance on these forward looking statements, which speak only as of the date hereof. All forward looking statements are qualified in their entirety by this cautionary statement, and Digirad undertakes no obligation to revise or update the forward looking statements contained herein.

    Investor Contact:
    Matt Clawson
    Allen & Caron
    949-474-4300
    Matt@allencaron.com

    Company Contact:
    Todd Clyde, CEO
    858-726-1600
    ir@digirad.com


'/>"/>
SOURCE Digirad Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Digirad Corporation Sells Northern California Service Hubs
2. Digirad Corporation to Release Fourth Quarter and Year-End Financial Results on February 5, 2009
3. Digirad Corporation Comments on Fourth Quarter Progress
4. Digirad Corporation CEO to Present at J.P. Morgan Healthcare Conference in San Francisco
5. Digirad Corporation Receives FDA 510(k) Clearance for nSPEED(R) Reconstruction Software for Improved Image Quality in Less Time With Less Radiation
6. Digirad Corporation Reports Financial Results for 2008 Second Quarter and Six Months
7. Digirad Corporation to Present at CapStone Small-Cap Investor Conference
8. Digirad Corporation to Present at Bank of America 2008 Health Care Conference
9. Digirad Corporation and University of Chicago Medical Center Sign Letter of Agreement
10. Digirad Corporation Reports Financial Results for First-Quarter 2008
11. Digirad Corporation to Release First Quarter Financial Results on April 24, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... McKinney, Texas (PRWEB) , ... February 24, 2017 , ... ... south to The Medical Center at Craig Ranch building at 8080 State Highway 121, ... Ranch Medical District with easy access to Highway 121. , As the practice has ...
(Date:2/24/2017)... , ... February 24, 2017 , ... The California ... conference convening academic faculty engaged in or interested in palliative care education and research. ... will be held in North County San Diego on Sept. 28 and 29, 2017, ...
(Date:2/24/2017)... ... February 24, 2017 , ... Indiana Fiber Network (IFN) President and CEO Kelly ... Dyer started as the Chairman of the Management Committee when IFN was originally ... including the recruitment of investor/owners and development of the business plan. He became ...
(Date:2/24/2017)... ... February 24, 2017 , ... Congratulations to Head Over Heels’ ... February 12th. Ms. Esparza qualified into this prestigious status after winning the ... Las Vegas, Nevada. Frida is one of approximately 25 gymnasts in the nation ...
(Date:2/23/2017)... ... February 23, 2017 , ... On February ... a letter to withdraw previous guidance issued by the Obama Administration ... guidance issued in May 2016 by the Obama Administration came in response to ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... , Feb. 23, 2017 The ... of the PhenoTest BC Kit, performed on the ... identify organisms that cause bloodstream infections and provide ... to respond to (antibiotic sensitivity). The test also ... provide this important information, which can guide antibiotic ...
(Date:2/24/2017)... 2017  Directors from Pharma To Market Pty Ltd and Ador ... resulting in the founding of Pharma To Market Pte Ltd, based ... are pleased to announce their expansion into Asia ... . The company are delighted to appoint Joelle Chia ... Singapore based entity. Joelle brings with her an ...
(Date:2/24/2017)... Medivir AB (Nasdaq Stockholm: MVIR) ... Board of Directors that will be submitted to the ... representatives of the company,s three largest shareholders at the ... accepted a seat on the Nomination Committee, and the ... Nomination Committee was as follows:  ...
Breaking Medicine Technology: